Heat Biologics Inc (HTBX)

6.330
+0.060(+0.96%)
After Hours
6.440
+0.110(+1.738%)
- Real-time Data
  • Volume:
    184,113
  • Bid/Ask:
    6.270/6.440
  • Day's Range:
    6.170 - 6.330

HTBX Overview

Prev. Close
6.27
Day's Range
6.17-6.33
Revenue
2.58M
Open
6.2
52 wk Range
5.22-17
EPS
-1.38
Volume
184,113
Market Cap
163.32M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
979,707
P/E Ratio
-
Beta
0.28
1-Year Change
-58.33%
Shares Outstanding
25,800,309
Next Earnings Date
Nov 15, 2021
What is your sentiment on Heat Biologics Inc?
or
Market is currently closed. Voting is open during market hours.

Heat Biologics Inc News

  • Heat Biologics added to Russell Microcap Index
    • BySeeking Alpha-

    At the conclusion of the annual Russell indexes reconstitution, US clinical-stage biopharmaceutical companyHeat Biologics (HTBX) will join the Russell Microcap Index.The move is...

  • VXRT, NOVN, HTBX and CRIS among midday movers
    • BySeeking Alpha-

    Gainers:Novan (NOVN) +74%. Urban One (UONE) +39%. Losers: Recon Technology (RCON) -63%.Orphazyme (ORPH) -48%.Curis (CRIS) -36%.Aptose Biosciences (APTO) -30%.

Heat Biologics Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuySellStrong SellSell
Technical IndicatorsStrong BuyStrong BuyStrong SellStrong SellStrong Buy
SummaryStrong BuyStrong BuyStrong SellStrong SellNeutral

Heat Biologics Inc Company Profile

Heat Biologics Inc Company Profile

Employees
39

Heat Biologics, Inc., a biopharmaceutical company, engages in the development of immunotherapies to activate patient’s immune system against cancer through T-cell activation and expansion. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating platform that functions as an immune activator to stimulate and expand T-cells; and ComPACT, which delivers antigen driven T-cell activation and specific co-stimulation in a single product. The company develops HS-110, which is in phase II clinical trials to treat patients with advanced non-small cell lung cancer; and HS-130 that is in phase I clinical trial for the treatment of advanced solid tumors. Its preclinical stage products include PTX-35, a humanized affinity matured monoclonal antibody, which is a functional agonist of human TNFRSF25; TNFRSF25 modulators for various immunotherapy approaches; and COVID-19 vaccine. Heat Biologics, Inc. has collaboration with Waisman Biomanufacturing to manufacture COVID-19 Vaccine. The company was incorporated in 2008 and is headquartered in Morrisville, North Carolina.

Read More
  • https://seekingalpha.com/news/3709052-heat-biologics-expands-rd-and-pre-clinical-capabilities
    0
    • https://seekingalpha.com/news/3705412-heat-biologics-records-biggest-one-day-gain-in-over-four-months?utm_source=investing.com&utm_medium=referral
      0
      • Heat Biologics (HTBX) ticks higher on U.S. Patent Application Titled 'GP96-BASED CANCER THERAPY'
        0
        • Will be at 9$ on the next 3 months. Who want to bet?
          0
          • its about nothing. In 3 months they need at least 20
            0
        • Wolf, what are you Shareholders are struggling
          0
          • Endless Fall A company without vision
            1
            • In... someone else?
              0
              • once the non vacines (moderna astra phizer) are found to be unsafe htbx will sky rocket. especially with its higher viability and the cancer connection.
                0
            • earnings?
              0
              • why rising up ?
                0
                • Karel Mannaert if you have 15000 4 in a single stock like this you must have a wallet about 2 million dollar....o if you have all money in this stock you  are a noob  ahahahhahaah
                  0
                • davide bon don't understand, I bought 5000 stocks on 3,43 and paid 15K Actually value is now 5000 x 10, so 50K. And i have even stocks on TRXC, BNGO, JAGX....
                  0
                • Karel Mannaert  u had to sold them in last  June for 12$, then buy again after split for 5$ and sell again weak ago for 18$ - profit would be 110k
                  0
              • Premarket up 30% ?
                0
                • 37%
                  0
              • The trend Is down...I think we will aspect a lot of month before ti arrive at 2€, price ti offering,..No news from socety...
                4
                • over 30$ in Summer
                  0
                  • picked-up another batch at 9.48
                    0
                    • Stock Trch buy special dividend
                      0
                      • TipRanks just report HTBX is strong buy . Target price $26.25 High $35.00 Low $20.00 is 138.20% Upside.
                        0
                        • hold
                          0
                          • And people said this is a garbage company.
                            0
                            • Its current market cap is less than 300M$. Taking into account its more than likely future income,its fair price should be at least 40$
                              1
                              • Everyone BUY BUY BUY
                                0
                                • If it tries to close that gap, then that will be another buy opportunity,
                                  0
                                  • waiting for a dip to buy😁
                                    0
                                    • They will heal cancer in the future, I hope. Very good company. 👍🏼
                                      0
                                      • Stop selling, we will see 20-25 US$ this week. 🙄🙄🙄
                                        0
                                        • just bought some more!  buy and hold.
                                          0
                                        • wich week do you meaned ....? :)
                                          0
                                      • zzz
                                        0
                                        • tomorrow 15 $ and then 20$?
                                          1
                                          Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                          Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.